Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System-Reference-Cited by-同舟云学术

Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System

Published:2023-01-13 Issue:2 Volume:43 Page:129-140
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Ogura Toru^ORCID,Shiraishi Chihiro^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-022-01242-7.pdf

Reference47 articles.

1. Drucker D, Easley C, Kirkpatrick P. Sitagliptin. Nat Rev Drug Discov. 2007;6(2):109–10. https://doi.org/10.1038/nrd2245.

2. Lyseng-Williamson KA. Sitagliptin. Drugs. 2007;67(4):587–97. https://doi.org/10.2165/00003495-200767040-00007.

3. Dhillon S. Sitagliptin. Drugs. 2010;70(4):489–512. https://doi.org/10.2165/11203790-000000000-00000.

4. Henness S, Keam SJ. Vildagliptin. Drugs. 2006;66(15):1989–2001. https://doi.org/10.2165/00003495-200666150-00007.

5. Croxtall JD, Keam SJ. Vildagliptin. Drugs. 2008;68(16):2387–409. https://doi.org/10.2165/0003495-200868160-00009.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Adverse Events Following Immunosuppressant Administration for Pediatric Patients With Renal Transplants Categorized by Two-Year Age Increments Using the U.S. Food and Drug Administration Adverse Event Reporting System;Cureus;2024-07-24

2. Efficacy of Prednisone Avoidance in Patients With Liver Transplant Using the U.S. Food and Drug Administration Adverse Event Reporting System;Cureus;2024-05-13

3. Analysis of Adverse Events Following Phenobarbital Administration for Pediatric Patients Categorized by One-Year Age Increments Using the U.S. Food and Drug Administration Adverse Event Reporting System;Cureus;2024-03-18

4. Proteomic changes related to actin cytoskeleton function in the skin of vildagliptin-treated mice;Journal of Dermatological Science;2024-03

5. Analysis of death avoidance by concomitant use of prednisone in patients with renal transplant using the Food and Drug Administration Adverse Event Reporting System;Transplant Immunology;2023-10